Lizeth Beltran

Eli Lilly CEO David Ricks is “disappointed” that only one in 10 Americans are on GLP-1s. The company, which is rolling out weight-loss pills designed to make the drugs more accessible to a larger part of the population, wants more people to add the drugs ... See more

The News US Interior Secretary Doug Burgum on Thursday said US oil and gas companies are open to some ideas, on a temporary basis, to help cut red tape and ultimately produce more oil. Speaking at Semafor World Economy in Washington, DC, Burgum disclosed ... See more

Restricting the ability to bring in the best foreign talent will hinder companies’ growth and in turn the US economy, the head of US biotech company, Flagship Pioneering, said at Semafor World Economy in Washington, DC. People who immigrated to the US did... See more

The US government needs to enshrine intellectual property rights of drugs that are discovered via AI, and embrace the technology’s power if the nation wants to stay ahead of China in the race of drug innovation, warned Luma Group founder Josh Fink at Sema... See more

Telehealth companies that offer GLP-1 drugs rewrote the playbook on how consumers obtain the once-pricey medications, health platform leaders said at Semafor World Economy in Washington, DC. “Because the majority of the population wanted them, providers w... See more